| ［1］ |
Sun H，Saeedi P，Karuranga S，et al.IDF Diabetes Atlas：Global，regional and country-level diabetes prevalence estimates for 2021 and projections for 2045［J］.Diabetes Res Clin Pract，2022，183：109-119.
|
| ［2］ |
刘涵，沈强，张蓝月，等.维生素与糖尿病视网膜病变的相关性［J］.生命的化学，2024，44（6）：1032-1038.
|
| ［3］ |
刘涵，沈强，张蓝月，等.糖尿病视网膜病变分子生物标志物的研究进展［J］.中华眼科医学杂志（电子版），2023，13（6）：376-380.
|
| ［4］ |
Sourris KC， Watson A， Jandeleit-Dahm K. Inhibitors of advanced glycation end product（AGE） formation and accumulation［J］.Handb Exp Pharmacol，2021，264：395-423.
|
| ［5］ |
Corica D，Pepe G，CurròM，et al.Methods to investigate advanced glycation end-product and their application in clinical practice［J］.Methods，2022，203：90-102.
|
| ［6］ |
Twarda-Clapa A，Olczak A，Białkowska AM，et al.Advanced glycation end-products （AGEs）： formation， chemistry，classification，receptors，and diseases related to AGEs［J］.Cells，2022，11（8）：1312.
|
| ［7］ |
Zhang Q，Wang Y，Fu L.Dietary advanced glycation endproducts： Perspectives linking food processing with health implications［J］.Compr Rev Food Sci Food Saf，2020，19（5）：2559-2587.
|
| ［8］ |
Liu J，Pan S，Wang X，et al.Role of advanced glycation end products in diabetic vascular injury：molecular mechanisms and therapeutic perspectives［J］.Eur J Med Res，2023，28（1）：553.
|
| ［9］ |
Snelson M，Tan SM，Clarke RE，et al.Processed foods drive intestinal barrier permeability and microvascular diseases［J］.Sci Adv，2021，7（14）：4841.
|
| ［10］ |
Jangde N，Ray R，Rai V.RAGE and its ligands：from pathogenesis to therapeutics［J］.Crit Rev Biochem Mol Biol，2020，55（6）：555-575.
|
| ［11］ |
Portillo JC，Pfaff A，Vos S，et al.Advanced glycation end products upregulate CD40 in human retinal endothelial and Müller cells：relevance to diabetic retinopathy［J］.Cells，2024，13（5）：429.
|
| ［12］ |
Shen CY，Lu CH，Wu CH，et al.The development of maillard reaction，and advanced glycation end product（AGE）-receptor for AGE（RAGE）signaling inhibitors as novel therapeutic strategies for patients with AGE-related diseases［J］.Molecules，2020，25（23）：5591.
|
| ［13］ |
Zawada A，Machowiak A，Rychter AM，et al.Accumulation of advanced glycation end-products in the body and dietary habits［J］.Nutrients，2022，14（19）：3982.
|
| ［14］ |
Kang Q，Yang C.Oxidative stress and diabetic retinopathy：Molecular mechanisms， pathogenetic role and therapeutic implications［J］.Redox Biol，2020，37：101799.
|
| ［15］ |
侯小玉，接传红，王建伟，等.线粒体DNA在糖尿病视网膜病变发病机制中的作用研究进展［J］.眼科新进展，2023，43（12）：992-996.
|
| ［16］ |
Sergi D，Boulestin H，Campbell FM，et al.The role of dietary advanced glycation end products in metabolic dysfunction［J］.Mol Nutr Food Res，2021，65（1）：900-934.
|
| ［17］ |
Khalid M，Petroianu G，Adem A.Advanced glycation end products and diabetes mellitus：mechanisms and perspectives［J］.Biomolecules，2022，12（4）：542.
|
| ［18］ |
Oshitari T. Advanced glycation end-products and diabetic neuropathy of the retina［J］.Int JMol Sci，2023，24（3）：2927.
|
| ［19］ |
Yuan T，Yang T，Chen H，et al.New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis［J］.Redox Biol，2019，20：247-260.
|
| ［20］ |
Burr SD，Stewart JA.Rap1a overlaps the AGE/RAGE signaling cascade to alter expression ofα-SMA，p-NF-κB，and p-PKC-ζin cardiac fibroblasts isolated from type 2 diabetic mice［J］.Cells，2021，10（3）：557.
|
| ［21］ |
Kang Q，Dai H，Jiang S，et al.Advanced glycation end products in diabetic retinopathy and phytochemical therapy［J］.Front Nutr，2022，9：1037186.
|
| ［22］ |
Roy S，Kim D.Retinal capillary basement membrane thickening：Role in the pathogenesis of diabetic retinopathy［J］.Prog Retin Eye Res，2021，82：100903.
|
| ［23］ |
Peña JS，Ramanujam RK，Risman RA，et al.Neurovascular relationships in AGEs-based models of proliferative diabetic retinopathy［J］.Bioengineering（Basel），2024，11（1）：63.
|
| ［24］ |
Bikbova G，Oshitari T，Bikbov M.Diabetic neuropathy of the retina and inflammation：perspectives［J］.Int J Mol Sci，2023，24（11）：9166.
|
| ［25］ |
Kuzan A.Toxicity of advanced glycation end products［J］.Biomed Rep，2021，14（5）：46.
|
| ［26］ |
Takeuchi M，Sakasai-Sakai A，Takata T，et al.Effects of toxic AGEs（TAGE） on human health［J］.Cells，2022，11（14）：2178.
|
| ［27］ |
Takayanagi Y，Yamanaka M，Fujihara J，et al.Evaluation of relevance between advanced glycation end products and diabetic retinopathy stages using skin autofluorescence［J］.Antioxidants（Basel），2020，9（11）：1100.
|
| ［28］ |
杨彩霞，夏利.血清晚期糖基化终末产物和血管内皮生长因子水平与2型糖尿病患者视网膜病变的关系［J］.中华实用诊断与治疗杂志，2023，37（7）：711-715.
|
| ［29］ |
Pramanik S，Banerjee K，Mondal LK.The Amelioration of Detrimental biochemical anomalies by supplementing B，C，and E vitamins in subjects with type2 diabetes mellitus may reduce the rate of development of diabetic retinopathy［J］.J Diabetes Res，2022，18（3）：3886710.
|
| ［30］ |
Allowitz KV，Yoo JJ，Taylor JR，et al.Therapeutic potential of vitamin B1 derivative benfotiamine from diabetes to COVID-19［J］.Future Med Chem，2022，14（11）：809-826.
|
| ［31］ |
Abdullah KM，Abul-Qais F，Hasan H，et al.Anti-diabetic study of vitamin B6 on hyperglycaemia induced protein carbonylation，DNA damage and ROSproduction in alloxan induced diabetic rats［J］.Toxicol Res（Camb），2019，8（4）：568-579.
|
| ［32］ |
Sun KX，Chen YY，Li Z，et al.Genipin relieves diabetic retinopathy by down-regulation of advanced glycation end products via the mitochondrial metabolism related signaling pathway［J］.World J Diabetes，2023，14（9）：1349-1368.
|
| ［33］ |
Sun K，Chen Y，Zheng S，et al.Genipin ameliorates diabetic retinopathy via the HIF-1α and AGEs-RAGE pathways［J］.Phytomedicine，2024，129：155596.
|
| ［34］ |
Liu J，Wang X.Butein inhibits the glycation ofα-crystallin：an approach in prevention of retinopathy［J］.J Fluoresc，2023，33（4）：1347-1358.
|
| ［35］ |
Xie M，Deng L，Yu Y，et al.The effects of Bushen Yiqi Huoxue prescription and its disassembled prescriptions on a diabetic retinopathy model in Sprague Dawley rats［J］. Biomed Pharmacother，2021，133：110920.
|
| ［36］ |
Arshi B，Chen J，Ikram MA，et al.Advanced glycation endproducts，cardiac function and heart failure in the general population：the rotterdam study［J］.Diabetologia，2023，66（3）：472-481.
|
| ［37］ |
Kao YW，Hsu SK，Chen JY，et al.Curcumin metabolite tetrahydrocurcumin in the treatment of eye diseases［J］.Int JMol Sci，2020，22（1）：212.
|
| ［38］ |
Yao B，Xin ZK，Wang D.The effect of curcumin on on intravitreal proinflammatory cytokines，oxidative stress markers，and vascular endothelial growth factor in an experimental model of diabetic retinopathy［J］.J Physiol Pharmacol，2023，74（6）：10.
|
| ［39］ |
Filippelli M，Campagna G，Vito P，et al.Anti-inflammatory effect of curcumin，homotaurine，and vitamin D3 on human vitreous in patients with diabetic retinopathy［J］.Front Neurol，2021，11：592274.
|
| ［40］ |
Maharjan P，Jin M，Kim D，et al.Evaluation of epithelial transport and oxidative stress protection of nanoengineered curcumin derivative-cyclodextrin formulation for ocular delivery［J］.Arch Pharm Res，2019，42（10）：909-925.
|
| ［41］ |
Gurbuz N，Gurkan R，Ender-Caylan A，et al.The therapeutic effect of ALT-711 on erectile function in rats treated with highlevel AGEs（advanced glycation end products）containing diet［J］.Int J Impot Res，2022，34（2）：222-228.
|
| ［42］ |
Singh H，Agrawal DK.Therapeutic potential of targeting the receptor for advanced glycation end products（RAGE）by small molecule inhibitors［J］.Drug Dev Res，2022，83（6）：1257-1269.
|
| ［43］ |
Khan MI，Ashfaq F，Alsayegh AA，et al.Advanced glycation end product signaling and metabolic complications：Dietary approach［J］.World J Diabetes，2023，14（7）：995-1012.
|
| ［44］ |
Amin R，Indiarsih TB，Sari PM，et al.Anti-RAGE（receptor advanced glycation end products）antibody improves diabetic retinopathy in rats via hypoglycemic and anti-inflammatory mechanism［J］.Rep Biochem Mol Biol，2022，11（3）：394-399.
|
| ［45］ |
Kozlyuk N，Gilston BA，Salay LE，et al.A fragment-based approach to discovery of receptor for advanced glycation end products inhibitors［J］.Proteins，2021，89（11）：1399-1412.
|
| ［46］ |
Ma S，Nakamura Y，Hisaoka-Nakashima K，et al.Blockade of receptor for advanced glycation end-products with azeliragon ameliorates streptozotocin-induced diabetic neuropathy［J］.Neurochem Int，2023，163：105470.
|
| ［47］ |
Apte MM，Khattar E，Tupe RS.Mechanistic role of Syzygium cumini（L.）Skeels in glycation induced diabetic nephropathy via RAGE-NF-κB pathway and extracellular proteins modifications：A molecular approach［J］.JEthnopharmacol，2024，322：117573.
|
| ［48］ |
Chandrakumar S， Santiago-Tierno I， Agarwal M， et al.Subendothelial matrix stiffening by lysyl oxidase enhances ragemediated retinal endothelial activation in diabetes［J］.Diabetes，2023，72（7）：973-985.
|
| ［49］ |
Yamagishi SI.Role of Advanced glycation endproduct（AGE）-receptor for advanced glycation endproduct（RAGE）axis in cardiovascular disease and its therapeutic intervention［J］.Circ J，2019，83（9）：1822-1828.
|